⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATOS News
Atossa Therapeutics, Inc. Common Stock
Atossa Therapeutics Receives FDA Orphan Drug Designation for (Z)-Endoxifen for the Treatment of Duchenne Muscular Dystrophy
prnewswire.com
ATOS
Europäische Unternehmen implementieren beschleunigt und verantwortungsbewusst KI
businesswire.com
III
ACN
ATOS
CGEM
HPE
IBM
INFY
MPW
UIS
DXC
LNG
MATH
SDG
TIGR
VRSN
WNS
TEL
DT
Les entreprises européennes accélèrent l’adoption responsable de l’IA
businesswire.com
III
ACN
ATOS
HPE
IBM
INFY
TDS
DXC
VRSN
European Enterprises Accelerate Responsible AI Adoption
businesswire.com
III
ACN
ATOS
IBM
INFY
TSI
UIS
DXC
MATH
TIGR
VRSN
WNS
Quantum Computing Market Report 2025-2035: Expected to Witness 14.5% CAGR - CNS Disorders Segment to Exhibit Highest Growth Among Therapeutic Areas
globenewswire.com
ACN
AMZN
ATOS
IBM
MSFT
Atossa Therapeutics Receives FDA "Study May Proceed" Letter for (Z)-Endoxifen Investigational New Drug Application for Metastatic Breast Cancer
prnewswire.com
ATOS
Avenga Appoints Clay Van Doren as Chief Executive Officer
globenewswire.com
ATOS
Quantum Computing in Financial Services Market Set to Reach USD 6.3 Billion by 2032 as Banks Move from Experimentation to Quantum Advantage | DataM Intelligence
prnewswire.com
IBM
INTC
IONQ
GOOG
AMZN
HON
GE
HPQ
CSCO
ATOS
Atos Group has signed a binding agreement to sell Ideal GRP, one of its Nordic businesses, to MAIT Group
globenewswire.com
ATOS
Sword Group selected as part of the ATOS-led consortium for the European Commission’s DG DIGIT FREIA – Lot 1 Framework contract
globenewswire.com
ATOS